These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 18415752

  • 1. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease.
    Von Hahn T, Halangk J, Witt H, Neumann K, Müller T, Puhl G, Neuhaus P, Nickel R, Beuers U, Wiedenmann B, Berg T.
    Scand J Gastroenterol; 2008; 43(5):584-92. PubMed ID: 18415752
    [Abstract] [Full Text] [Related]

  • 2. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
    Baumgart DC, Buning C, Geerdts L, Schmidt HH, Genschel J, Fiedler T, Gentz E, Molnar T, Nagy F, Lonovics J, Lochs H, Wiedenmann B, Nickel R, Witt H, Dignass A.
    Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
    [Abstract] [Full Text] [Related]

  • 3. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.
    Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO.
    Hepatology; 2001 May; 33(5):1148-53. PubMed ID: 11343243
    [Abstract] [Full Text] [Related]

  • 4. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both.
    Dezsofi A, Szebeni B, Hermann CS, Kapitány A, Veres G, Sipka S, Körner A, Madácsy L, Korponay-Szabó I, Rajczy K, Arató A.
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):283-7. PubMed ID: 18728522
    [Abstract] [Full Text] [Related]

  • 5. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens.
    Schulz S, Zissler N, Altermann W, Klapproth J, Zimmermann U, Gläser C, Schaller HG, Reichert S.
    Int J Immunogenet; 2008 Dec; 35(6):457-64. PubMed ID: 19046305
    [Abstract] [Full Text] [Related]

  • 6. The effect of polymorphisms at the CD14 promoter and the TLR4 gene on asthma phenotypes in Turkish children with asthma.
    Saçkesen C, Karaaslan C, Keskin O, Tokol N, Tahan F, Civelek E, Soyer OU, Adalioglu G, Tuncer A, Birben E, Oner C, Kalayci O.
    Allergy; 2005 Dec; 60(12):1485-92. PubMed ID: 16266379
    [Abstract] [Full Text] [Related]

  • 7. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B.
    Hepatogastroenterology; 2005 Dec; 52(63):808-11. PubMed ID: 15966209
    [Abstract] [Full Text] [Related]

  • 8. The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients.
    Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M.
    Intensive Care Med; 2002 Aug; 28(8):1161-3. PubMed ID: 12185442
    [Abstract] [Full Text] [Related]

  • 9. Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease.
    Vainas T, Stassen FR, Bruggeman CA, Welten RJ, van den Akker LH, Kitslaar PJ, Peña AS, Morré SA.
    J Vasc Surg; 2006 Aug; 44(2):326-32. PubMed ID: 16890863
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients.
    Nezi V, Deutsch M, Gazouli M, Alexopoulou A, Paparrigopoulos T, Liappas IA, Dourakis SP.
    Alcohol Clin Exp Res; 2013 Feb; 37(2):244-51. PubMed ID: 23009036
    [Abstract] [Full Text] [Related]

  • 11. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis.
    Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY.
    J Infect Dis; 2007 Dec 01; 196(11):1698-706. PubMed ID: 18008256
    [Abstract] [Full Text] [Related]

  • 12. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
    van der Paardt M, Crusius JB, de Koning MH, Morré SA, van de Stadt RJ, Dijkmans BA, Peña AS, van der Horst-Bruinsma IE.
    Ann Rheum Dis; 2005 Feb 01; 64(2):235-8. PubMed ID: 15647432
    [Abstract] [Full Text] [Related]

  • 13. Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury.
    Riordan SM, Skinner NA, Kurtovic J, Locarnini S, McIver CJ, Williams R, Visvanathan K.
    Inflamm Res; 2006 Jul 01; 55(7):279-85. PubMed ID: 16955390
    [Abstract] [Full Text] [Related]

  • 14. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis.
    Shih HH, Lin TM, Chuang JH, Eng HL, Juo SH, Huang FC, Chen CL, Chen HL.
    Pediatrics; 2005 Aug 01; 116(2):437-41. PubMed ID: 16061600
    [Abstract] [Full Text] [Related]

  • 15. Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study.
    Smit LA, Bongers SI, Ruven HJ, Rijkers GT, Wouters IM, Heederik D, Omland Ø, Sigsgaard T.
    Clin Exp Allergy; 2007 Nov 01; 37(11):1602-8. PubMed ID: 17877764
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation.
    Hwang YH, Ro H, Choi I, Kim H, Oh KH, Hwang JI, Park MH, Kim S, Yang J, Ahn C.
    Transplantation; 2009 Sep 15; 88(5):699-705. PubMed ID: 19741468
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms in the tumor necrosis factor/lipopolysaccharides pathway in Crohn disease in the Jewish Ashkenazi population.
    Silbermintz A, Levine J, Weinstein T, Silver J.
    J Pediatr Gastroenterol Nutr; 2008 May 15; 46(5):546-50. PubMed ID: 18493210
    [Abstract] [Full Text] [Related]

  • 20. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML, Kennedy M, Roberts R, Shelling AN, Philpott M, Han DY, Ferguson LR.
    Hum Immunol; 2009 Jun 15; 70(6):440-6. PubMed ID: 19275920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.